Abstract:IMPORTANCE It remains unknown whether neurodevelopmental impairments are directly associated with the structural development of the brain in offspring with fetal growth restriction (FGR) and mothers with preeclampsia (PE) or gestational hypertension (GH). OBJECTIVES To assess whether fetal corpus callosum (CC) development differed among pregnancies with PE or GH with FGR, pregnancies with PE or GH without FGR, and normotensive pregnancies, particularly the severity of maternal disease and FGR, and to identify the association between adverse perinatal outcomes and structural development of the CC in fetuses with FGR in pregnancies with PE or GH. DESIGN, SETTING, AND PARTICIPANTS This retrospective matched case-control study was conducted between January 1, 2014, and January 31, 2021, at Women's Hospital, Zhejiang University School of Medicine in Hangzhou, China. The participant group included cases of singleton pregnancies with PE or GH with FGR; the control groups included cases with PG or GH without FGR and cases with paired normotensive pregnancy. EXPOSURES Maternal PE or GH and FGR. MAIN OUTCOMES AND MEASURES The length, thickness, total area, subdivision areas, and apparent diffusion coefficient (ADC) values of fetal CC were measured on magnetic resonance imaging (MRI) and analyzed. The association between adverse perinatal outcomes and structural development of CC was further investigated. RESULTS A total of 56 pregnant individuals with singleton pregnancies and PE or GH and fetuses with FGR were enrolled (maternal median [IQR] age, 29.0 [26.0-34.0] years; mean [SD] gestational age at MRI, 33.6 [2.5] weeks). Significant patterns of decreased median (IQR)fetal CC length (0.4284 [0.4079-0.4470] mm vs 0.4614 [0.4461-0.4944] mm, P < .001, vs 0.4591[0.4310-0.4927] mm, P < .001) and mean (SD) CC total area (1.0779 [0.1931] mm(2) vs 1.1896 [0.1803] mm(2), P = .001, vs 1.1438 [0.1935] mm(2), P = .02), adjusted for the cephalic index, was observed in cases of PE or GH with FGR compared with cases without FGR and cases with normotensive pregnancy. The splenium region of fetal CC also exhibited the distinct alterations in macrostructural development (with FGR: 0.3149 [0.0697] mm(2) vs without FGR: 0.3727 [0.0698] mm(2), P < .001, vs normotensive pregnancies: 0.3565 [0.0763] mm(2), P < .001) and microstructural development (median [IQR] ADC values: 1.47 [1.38-1.57] x 10(-3) mm(2)/s vs 1.57 [1.53-1.63] x 10(-3) mm(2)/s. P = .009. vs 1.63 [1.501.70] x 10(-3) mm(2)/s. P < .001) in all groups. Furthermore, significant associations were found between structural abnormality of the splenium region and adverse perinatal outcomes in the PE or GH with FGR group (mean [SD] ADC value:1.40 [0.07] x 10(-3) mm(2)/s; P = .04). CONCLUSIONS AND RELEVANCE Results of this study suggest that, in fetuses with FGR in pregnancies with PE or GH, decreased structural development of the CC, predominantly the splenium region, may be significantly associated with a higher risk of adverse perinatal outcomes and may be regarded as an MRI-based biomarker for better prenatal counseling and early management decisions.

Fetal agenesis of corpus callosum: chromosomal copy number abnormalities and postnatal follow-up

Whole-Exome Sequencing Revealed Mutations of MED12 and EFNB1 in Fetal Agenesis of the Corpus Callosum

Genetic etiology of agenesis of the corpus callosum: a retrospective single-center cohort analysis of 114 fetuses

Outcomes Associated With Isolated Agenesis of the Corpus Callosum: A Meta-analysis

Isolated Complete Agenesis of Corpus Callosum.

Association of Corpus Callosum Development with Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension.

Retrospective analysis of the prognostic factors of fetal corpus callosum dysplasia

An Approach to Screen Fetal Agenesis of the Corpus Callosum at 11-13~(+6) Weeks

Prenatal diagnosis and molecular cytogenetic characterization of fetuses with central nervous system anomalies using chromosomal microarray analysis: a seven-year single-center retrospective study

OP06.05: the Usefulness of Prenatal Imaging Features in Discovering Pathogenic Genomic Variations in Fetal Agenesis of Corpus Callosum

MRI Diagnosis of Fetal Corpus Callosum Agenesis

Chromosomal Abnormality in Fetuses with Isolated Antenatal Hydronephrosis: Update for Prenatal Diagnosis and Genetic Counseling

OC06.04: Application of prenatal ultrasound combined with fast MRI in the diagnosis of fetal agenesis of corpus callosum

Clinical Experience of Prenatal Chromosomal Microarray Analysis in 6159 Ultrasonically Abnormal Fetuses

A control study between prenatal ultrasound, magnetic resonance imaging and pathological results in fetal agenesis of the corpus callosum

Chromosomal Microarray Analysis in Fetuses with Ultrasound Abnormalities

Magnetic Resonance Imaging (MRI) Diagnosis of Fetal Corpus Callosum Abnormalities and Follow-up Analysis

Residual risk of clinically significant copy number variations in fetuses with nasal bone absence or hypoplasia after excluding non-invasive prenatal screening-detectable findings

Perinatal outcomes after a prenatal diagnosis of a fetal copy number variant: a retrospective population-based cohort study

Prenatal diagnosis of fetuses with absent/hypoplastic nasal bone in second‐trimester using chromosomal microarray analysis

Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study